A01N63/00

Methods and Compositions for Nutrient Enrichment in Plants
20210112768 · 2021-04-22 ·

This disclosure describes compositions and methods for delivering nutrients (e.g., nitrogen) to plants.

AGRICULTURAL MICROBIAL COATING
20210106009 · 2021-04-15 ·

A method for making a coating material by selecting a microbial mixture with a predetermined microbial population characteristics for predetermined plant growth property; using genetic testing to verify the presence of the microbial population characteristics and iteratively growing the mixture with the predetermined microbial population characteristics in a feedback loop; and combining the microbial mixture with a cross-linked hydrophilic mixture.

AGRICULTURAL MICROBIAL COATING
20210106009 · 2021-04-15 ·

A method for making a coating material by selecting a microbial mixture with a predetermined microbial population characteristics for predetermined plant growth property; using genetic testing to verify the presence of the microbial population characteristics and iteratively growing the mixture with the predetermined microbial population characteristics in a feedback loop; and combining the microbial mixture with a cross-linked hydrophilic mixture.

Composition comprising bacillus

The present invention refers to a composition comprising Bacillus subtilis (DSM 17231) and Bacillus licheniformis (DSM 17236) with nematicidal effect against phytonematodes on plants and/or its habitat, to its use and process for its preparation, use of Bacillus subtilis (DSM 17231) and Bacillus licheniformis (DSM 17236), processes for controlling, combating and conferring specific resistance to phytonematodes, and a kit.

PHAGE THERAPY OF E COLI INFECTIONS
20210060100 · 2021-03-04 ·

The present invention relates to bacteriophage therapy. More particularly, the present invention relates to novel bacteriophages having a high specificity against Escherichia coli strains, their manufacture, components thereof, compositions comprising the same and the uses thereof in phage therapy.

Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy
10961538 · 2021-03-30 · ·

In one embodiment, a single modality cancer immunotherapy regimen that includes a therapeutic composition is provided. Such a therapeutic composition may include a Salmonella strain comprising a plasmid that expresses an shRNA molecule that suppresses the expression of an immunosuppressive target and suppresses tumor growth. In some aspects, the Salmonella strain is an attenuated Salmonella typhimurium strain. In other aspects, the immunosuppressive target is STAT3, IDO1, IDO2, Arginase 1, iNOS, CTLA-4, TGF-, IL-10, pGE2 or VEGF. In one embodiment, the immunosuppressive target is IDO1 or Arg1 and the shRNA molecule is any one of SEQ ID NO:5-14.

Poultry farm practices

The present invention relates to methods of improving the environment within a poultry farming facility including reducing ammonia production in a poultry facility, inhibiting urease enzymes in poultry litter, reducing levels of pathogenic bacteria in poultry litter, improving productivity of poultry farms, reducing or preventing pododermatitis in poultry reared in mass production poultry facilities and controlling pests in poultry litter. Compositions, suitable for use in such methods, comprising at least one microorganism of the genus Bacillus and at least one biosurfactant wherein the biosurfactant is present in an amount of 2 mg/L to 7000 mg/L are also described.

SEQUENCE SPECIFIC ANTIMICROBIALS
20210060140 · 2021-03-04 ·

Provided are compositions and methods for selectively reducing the amount of antibiotic resistant and/or virulent bacteria in a mixed bacteria population, or for reducing any other type of unwanted bacteria in a mixed bacteria population. The compositions and methods involve targeting bacteria that are differentiated from other members of the population by at least one unique clustered regularly interspaced short palindromic repeats (CRISPR) targeted DNA sequence. The compositions and methods can be readily adapted to target any bacteria or any bacteria plasmid, or both.

SEQUENCE SPECIFIC ANTIMICROBIALS
20210060140 · 2021-03-04 ·

Provided are compositions and methods for selectively reducing the amount of antibiotic resistant and/or virulent bacteria in a mixed bacteria population, or for reducing any other type of unwanted bacteria in a mixed bacteria population. The compositions and methods involve targeting bacteria that are differentiated from other members of the population by at least one unique clustered regularly interspaced short palindromic repeats (CRISPR) targeted DNA sequence. The compositions and methods can be readily adapted to target any bacteria or any bacteria plasmid, or both.

SEQUENCE SPECIFIC ANTIMICROBIALS
20210060141 · 2021-03-04 ·

Provided are compositions and methods for selectively reducing the amount of antibiotic resistant and/or virulent bacteria in a mixed bacteria population, or for reducing any other type of unwanted bacteria in a mixed bacteria population. The compositions and methods involve targeting bacteria that are differentiated from other members of the population by at least one unique clustered regularly interspaced short palindromic repeats (CRISPR) targeted DNA sequence. The compositions and methods can be readily adapted to target any bacteria or any bacteria plasmid, or both.